Skip to main content
OpenTrials
Recruiting

NCT Number: NCT07272005

Improving Control of Intermittent Exotropia

To determine whether use of dichoptic movies for 8 weeks may be helpful in improving control alignment in children with intermittent exotropia (IXT), thus allowing IXT to be managed non-surgically

Recruiting

Interested in participating?

Request Info

Key information

Age range

4 year–10 year

Sex eligibility

All sexes

Study type

Interventional

Phase

Not applicable

Primary location

Retina Foundation of the Southwest

Dallas, Texas, 75231, United States

Location status: Recruiting

Location contact

Eileen E Birch, PhD

PRINCIPAL_INVESTIGATOR

Pediatric Laboratory

CONTACT

2143633911 ext. 113

About this study

Intermittent exotropia (IXT) is the most common form of strabismus, characterized by an outward deviation of the eyes that is primarily manifest during distance fixation and can intermittently be controlled by fusional mechanisms. Less than 30% of children have good long-term outcomes following treatment for spontaneously manifest IXT with current non-surgical treatments (prism therapy, over-minus lenses, or vision therapy). The limited efficacy of current non-surgical treatments for IXT is thought to arise from underlying sensory deficits, particularly interocular suppression, which compromises binocular function. This underscores the need for sensory-directed interventions aimed at reducing suppression and thereby enhancing the potential for stable binocular outcomes.

In this study, children will be randomized to watch engaging videos streamed at home that are either dichoptic or standard (control) format. The aim is to determine whether the dichoptic format will decrease suppression and improve control of eye alignment . In previous research, use of dichoptic games and movies by children with amblyopia has shown to reduce suppression.

Who can participate

Healthy volunteers accepted: No

Only the study team can determine whether someone qualifies for participation.

Inclusion criteria

  • Diagnosis of IXT or XT at Distance & IXT or XP at near (Basic or Pseudo Divergence Excess subtype of IXT)
  • No surgery planned for 6 months

Exclusion criteria

  • Prior eye muscle surgery
  • Prior binocular treatment or vision therapy
  • Amblyopia
  • Neurological conditions, seizure disorders, vestibular abnormalities, or frequent headache
  • Other eye conditions (refractive error OK)

Treatment and study plan

dichoptic videos

Other

custom designed dichoptic videos

standard videos

Other

standard videos

Primary outcomes

  1. Improvement in control of intermittent exotropia

    Time frame: 8 weeks

    change percent time alignment is present at 8 weeks vs at baseline

Secondary outcomes

  1. Improvement in control of intermittent exotropia

    Time frame: 4 weeks

    change percent time alignment is present at 4 weeks vs at baseline

  2. Improvement in control of intermittent exotropia

    Time frame: 12 weeks off-treatment

    change percent time alignment is present at 12 weeks off-treatment weeks vs at baseline

  3. Change in distance stereoacuity

    Time frame: 4 weeks

    change in Distance Randot test score at 4 weeks vs at baseline

  4. Change in distance stereoacuity

    Time frame: 8 weeks

    change in Distance Randot test score at 8 weeks vs at baseline

  5. Change in distance stereoacuity

    Time frame: 12 weeks off-treatment

    change in Distance Randot test score at 12 weeks off-treatment vs at baseline

  6. Change in quality of life

    Time frame: 8 weeks

    Change in IXTQ questionnaire (Rasch-scored on a 0-100 scale) at 8 weeks vs at baseline

  7. Change in quality of life

    Time frame: 12 weeks off-treatment

    Change in IXTQ questionnaire (Rasch-scored on a 0-100 scale) ay 12 weeks off-treatment vs at baseline

Study contacts

Contact information is provided by the study sponsor or research team.

Eileen Birch, PhD

CONTACT

[email protected]

2143633911

Reed Jost, MS

CONTACT

[email protected]

2143633911

Sponsors and collaborators

Lead sponsor

Retina Foundation of the Southwest

Other

Registry information

Important dates

Study start
2026
Primary completion
2028
Study completion
2028
First posted
Dec 9, 2025
Registry last updated
Apr 8, 2026

OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.

View the official ClinicalTrials.gov record (opens in a new tab)

This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.

Published trials that share one or more normalized conditions with this study.